SIRT1 contributes to neuroendocrine differentiation of prostate cancer

被引:24
|
作者
Ruan, Lin [1 ,2 ]
Wang, Lei [3 ]
Wang, Xiaosong [1 ,4 ]
He, Ming [1 ,4 ]
Yao, Xiaoguang [1 ,4 ]
机构
[1] Hebei Univ Chinese Med, Hebei Key Lab Integrat Med Liver Kidney Patterns, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Dept Nephrol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
[3] Hebei Med Univ, Dept Urol, Hosp 1, Shijiazhuang, Hebei, Peoples R China
[4] Hebei Univ Chinese Med, Coll Integrat Med, Shijiazhuang, Hebei, Peoples R China
关键词
prostate cancer; SIRT1; neuroendocrine; N-Myc; Akt; OXIDATIVE STRESS; CELL-SURVIVAL; RESISTANT; EXPRESSION; P53; PROMOTES; MODULATION; APOPTOSIS; AUTOPHAGY; GENOMICS;
D O I
10.18632/oncotarget.23111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The epigenetic factor SIRT1 can promote prostate cancer progression, but it is unclear whether SIRT1 contributes to neuroendocrine differentiation. In this study, we showed that androgen deprivation can induce reactive oxygen species production and that reactive oxygen species, in turn, activate SIRT1 expression. The increased SIRT1 expression induces neuroendocrine differentiation of prostate cancer cells by activating the Akt pathway. In addition, the interaction between Akt and SIRT1 is independent of N-Myc and can drive the development of neuroendocrine prostate cancer when N-Myc is blocked. Furthermore, SIRT1 facilitates tumor maintenance, and targeting SIRT1 may reduce the tumor burden during androgen deprivation. Our findings suggest that SIRT1 is a potential target for therapeutic intervention.
引用
下载
收藏
页码:2002 / 2016
页数:15
相关论文
共 50 条
  • [41] SIRT1 Promotes Differentiation of Normal Human Keratinocytes
    Blander, Gil
    Bhimavarapu, Anupama
    Mammone, Thomas
    Maes, Daniel
    Elliston, Keith
    Reich, Christian
    Matsui, Mary Steidl
    Guarente, Leonard
    Loureiro, Joseph Jorge
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (01) : 41 - 49
  • [42] Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer A TARGET FOR PROSTATE CANCER MANAGEMENT VIA ITS INHIBITION?
    Jung-Hynes, Brittney
    Nihal, Minakshi
    Zhong, Weixiong
    Ahmad, Nihal
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (06) : 3823 - 3832
  • [43] SIRT1 inhibition-induced senescence as a strategy to prevent prostate cancer progression
    Huang, Shih-Bo
    Rivas, Paul
    Yang, Xiaoyu
    Lai, Zhao
    Chen, Yidong
    Schadler, Keri L.
    Hu, Ming
    Reddick, Robert L.
    Ghosh, Rita
    Kumar, Addanki P.
    MOLECULAR CARCINOGENESIS, 2022, 61 (07) : 702 - 716
  • [44] SIRT1 Modulates the Sensitivity of Prostate Cancer Cells to Vesicular Stomatitis Virus Oncolysis
    Muscolini, Michela
    Castiello, Luciano
    Palermo, Enrico
    Zevini, Alessandra
    Ferrari, Matteo
    Olagnier, David
    Hiscott, John
    JOURNAL OF VIROLOGY, 2019, 93 (15)
  • [45] Targeting SIRT1 impairs chemoresistance of prostate cancer cells by a synthesized anthraquinone derivatives
    Chen, Yi-Ling
    Hsu, Hsue-Yin
    CANCER SCIENCE, 2018, 109 : 990 - 990
  • [46] Screening of SirT1 activating compounds and their cytotoxicity in prostate cancer cell lines.
    Fu, Maofu
    Pattabiraman, Nagarajan
    Wang, Chenguang
    Ju, Xiaoming
    Sauve, Anthony
    Pestell, Richard G.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Neuroendocrine differentiation of prostate cancer and clinical outcome of Everolimus against neuroendocrine prostate cancer (NEPC)
    Shimomura, Tatsuya
    Kurauti, Takashi
    Sakanaka, Keigo
    Suzuki, Hidenori
    Goto, Hirokazu
    Endo, Yasuhiko
    Egawa, Shin
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 359 - 359
  • [48] SIRT1 Contributes for DHA Transport Across BeWo Cells.
    Mishra, Jay S.
    Hattis, Sari
    Mukhtarova, Marmin
    Dangudubiyyam, Sri V.
    Kumar, Sathish
    REPRODUCTIVE SCIENCES, 2020, 27 (SUPPL 1) : 337A - 337A
  • [49] Human ASH1 expression in prostate cancer with neuroendocrine differentiation
    Rapa, Ida
    Ceppi, Paolo
    Bollito, Enrico
    Rosas, Rosj
    Cappia, Susanna
    Bacillo, Elisa
    Porpiglia, Francesco
    Berruti, Alfredo
    Papotti, Mauro
    Volante, Marco
    MODERN PATHOLOGY, 2008, 21 (06) : 700 - 707
  • [50] Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2
    Diaz, M
    Abdul, M
    Hoosein, N
    PROSTATE, 1998, : 32 - 36